DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ecotrin (Aspirin Enteric Coated) - Published Studies

 
 



Ecotrin Related Published Studies

Well-designed clinical trials related to Ecotrin (Aspirin)

Initial 3-Weeks' Apixaban Versus Dual-Antiplatelet Therapy (Clopidogrel and Aspirin) Followed by Clopidogrel Alone in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): Study Protocol for a Randomized Controlled Trial. [2014]

Augmentation of citalopram with aspirin for treating major depressive disorder, a double blind randomized placebo controlled clinical trial. [2014]

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial). [2014]

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. [2014]

Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. [2014]

Aspirin and serum estrogens in postmenopausal women: a randomized controlled clinical trial. [2014]

Aspirin for prevention and treatment of venous thromboembolism. [2014]

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. [2013]

Aspirin with or without an antiemetic for acute migraine headaches in adults. [2013]

The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor. [2013]

Comparison of aspirin plus heparin with heparin alone on asymptomatic perioperative deep vein thrombosis in candidates for elective off-pump coronary artery bypass graft: a randomized clinical trial. [2013]

Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. [2013]

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. [2012]

Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion). [2012]

Evaluation of onset of pain relief from micronized aspirin in a dental pain model. [2012]

Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. [2011.12]

Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. [2011.12]

Impact of a Fixed-Dose Combination of Naproxen and Esomeprazole Magnesium on Serum Thromboxane B(2) Inhibition by Low-Dose Aspirin Over 5 Days in Healthy Adults: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial. [2011.11.09]

Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis. [2011.11]

A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel. [2011.09.15]

Aspirin use and breast cancer risk: a meta-analysis. [2011.09.04]

Platelet response to aspirin 50 and 100 mg in patients with coronary heart disease over a five-year period. [2011.09.01]

Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. [2011.09]

Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia. [2011.07]

Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. [2011.07]

Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. [2011.06.28]

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. [2011.06.11]

Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial. [2011.06]

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation. [2011.06]

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. [2011.06]

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. [2011.05]

Use of aspirin associates with longer primary patency of hemodialysis grafts. [2011.04]

The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinical and biochemical study). [2011.04]

Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial. [2011.03.10]

Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial. [2011.03]

Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization detected with ambulatory transcranial Doppler: a randomized trial. [2011.03]

Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. [2011.03]

Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. [2011.03]

Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial. [2011.02]

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. [2011.01.19]

Evaluation of small bowel blood flow in healthy subjects receiving low-dose aspirin. [2011.01.14]

A randomized pilot trial for aggressive therapeutic approaches in aspirin-resistant patients undergoing percutaneous coronary intervention. [2011.01]

Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study. [2011.01]

Effects of zinc-L-carnosine and vitamin E on aspirin-induced gastroduodenal injury in dogs. [2011.01]

Comparison of the effect of cilostazol with aspirin on circulating endothelial progenitor cells and small-dense LDL cholesterol in diabetic patients with cerebral ischemia: a randomized controlled pilot trial. [2011]

The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial. [2011]

The effect of aspirin on C-reactive protein in hypertensive patients. [2011]

The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial. [2011]

Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds - gastrointestinal adverse effects: a meta-analysis of randomized clinical trials. [2011]

Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy. [2011]

Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia. [2011]

Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization detected with ambulatory transcranial Doppler: a randomized trial. [2011]

Effects of zinc-L-carnosine and vitamin E on aspirin-induced gastroduodenal injury in dogs. [2011]

Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. [2010.12.21]

Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. [2010.12]

Results of the Cilostazol Stroke Prevention Study II (CSPS II), a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients. [2010.11]

Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. [2010.09.14]

Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. [2010.09]

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme. [2010.07]

Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. [2010.06.15]

Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. [2010.06.01]

Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting. [2010.06]

Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2. [2010.06]

Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy. [2010.06]

Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus. [2010.06]

Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent. [2010.06]

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. [2010.05.27]

Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease. [2010.05.01]

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. [2010.05]

[Investigation of the effects of low dose aspirin therapy on primary and secondary prevention of cardiovascular disease] [2010.05]

Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to "aspirin resistance". [2010.05]

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. [2010.05]

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. [2010.04.29]

Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). [2010.04.15]

Low-dose aspirin in the primary prevention of rheumatoid arthritis: the Women's Health Study. [2010.04]

Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. [2010.04]

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. [2010.03.03]

Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery. [2010.03.01]

Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors. [2010.03]

Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events. [2010.03]

To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. [2010.03]

Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. [2010.03]

Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial. [2010.02]

Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. [2010.02]

Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. [2010.01.12]

Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. [2010.01.05]

Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. [2010.01]

Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia. [2010]

Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. [2010]

Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study. [2010]

Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation. [2010]

Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. [2010]

Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. [2010]

Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting. [2010]

Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to "aspirin resistance". [2010]

Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. [2010]

Aspirin with or without an antiemetic for acute migraine headaches in adults. [2010]

Low-dose aspirin in the primary prevention of rheumatoid arthritis: the Women's Health Study. [2010]

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. [2010]

Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial. [2010]

Low-Dose Aspirin and Medical Record-Confirmed Age-Related Macular Degeneration in a Randomized Trial of Women. [2009.10.06]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017